Valuation
AVXLAnavex Life Sciences Corp.
StockNasdaqUnited StatesHealth careEU retail: available
−2.2% today · −84.8% over a year
No score: too little data.
Trend, Stability: among the weakest. No dividend.
Ratios vs sector
Medians of Health care companies in the same region (stocks and REITs).
| Metric | AVXL | Sector median | vs median |
|---|---|---|---|
| P/E | — | 30.4 · n=150 | — |
| P/B | 1.1 | 3.8 · n=305 | 71% below |
| P/S | — | 4.3 · n=297 | — |
| EV/EBIT | — | 25.9 · n=137 | — |
| Free-cash-flow yield | — | 1.5% · n=287 | — |
| Dividend yield | 0.00% | 0.00% · n=358 | — |
| Return on equity | −12.8% | −5.1% · n=306 | — |
| Return on invested capital | — | −0.3% · n=276 | — |
| Gross margin | — | 61.2% · n=202 | — |
| Net debt / EBITDA | — | 1.31 · n=144 | — |
Sector peers
The largest companies of the same sector and region.
| Instrument | P/E | P/B | EV/EBIT | Free-cash-flow yield | Dividend yield | Smart Score |
|---|---|---|---|---|---|---|
| LLYEli Lilly & Co | 44.9 | 35.4 | — | 1.5% | 0.6% | 7/10 |
| JNJJohnson & Johnson | 39.5 | 7.8 | — | 3.2% | 2.0% | 8/10 |
| ABBVAbbVie | 80.5 | — | 33.7 | 3.6% | 3.0% | 5/10 |
| UNHUnitedHealth | 26.6 | 3.6 | 19.5 | 6.3% | 2.2% | 9/10 |
| MRKMerck | 113.0 | 8.5 | — | 4.5% | 2.3% | 9/10 |
| TMOThermo Fisher Scientific | 35.8 | 4.7 | 35.3 | 2.9% | 0.3% | 9/10 |
| AMGNAmgen | 27.2 | 20.3 | 24.6 | 4.3% | 2.3% | 7/10 |
| GILDGILEAD | — | 16.4 | — | 6.7% | 2.1% | 5/10 |
| ABTAbbott | 28.7 | 3.5 | 27.0 | 4.1% | 3.0% | 6/10 |
| PFEPfizer | 39.5 | 2.0 | — | 6.4% | 7.2% | 1/10 |
Fiscal-year history
From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.
Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Jun 2026 · filed 28 Aug 2026
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.